New Zealand vs United Arab Emirates: Treatment success rate for patients treated for MDR-TB
New Zealand
100.0%
in 2022
United Arab Emirates
100.0%
in 2022
New Zealand rank
1st
United Arab Emirates rank
1st
Treatment success rate for patients treated for MDR-TB over time
- New Zealand
- United Arab Emirates
How they compare
New Zealand currently reports 100.0% against 100.0% in United Arab Emirates, a difference of 0.0%.
The two have swapped places 2 times across 9 shared years of data; in 2007 it was United Arab Emirates ahead.
New Zealand ranks 1st and United Arab Emirates ranks 1st of 163 countries.
Across the 3 decades both report, New Zealand averaged higher in 1 and United Arab Emirates in 1.
Head to head by decade
| Decade | New Zealand | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 46.5% | 100.0% | 53.5% | United Arab Emirates |
| 2010s | 55.5% | 25.0% | 30.5% | New Zealand |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, New Zealand or United Arab Emirates?
- New Zealand, at 100.0% against 100.0% in United Arab Emirates as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between New Zealand and United Arab Emirates?
- 0.0%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and United Arab Emirates?
- 9 years are reported by both, from 2007 to 2022.
- How do New Zealand and United Arab Emirates rank globally for treatment success rate for patients treated for mdr-tb?
- New Zealand ranks 1st and United Arab Emirates ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.